phrma logo

PhRMA

PhRMA Sites

Login

Explore Member-Only Resources

Access exclusive advocacy, policy, and research materials through the member site.

Login now

About

About

Our Agenda

Our Agenda

Policy Issues

We believe that patients should have access to innovative medicines.

Learn More

Innovation Ecosystem

Intellectual Property

Research & Development

Future of Medicine

Government Price Setting

International

Innovation Ecosystem

Patient Access & Affordability

PBMs & Middlemen

Hospitals and 340B

Insurance Coverage

Cost of Medicines

Medicare & Medicaid

Patient Access & Affordability

Resources

Our mission is to conduct effective advocacy for public policies that encourage the discovery of important, new medicines for patients by biopharmaceutical research companies.

Learn More

Resources

Resources

Newsroom

Newsroom

Blog

Blog

America's Medicines

PhRMA Foundation

PhRMA Foundation Logo

Voters for Cures

VotersForCures.org Logo

Working for Cures

workersforcures.org logo

This is Innovation

Innovation.org logo

View More

Search in PhRMA

Find resources, news, and articles related to policy issues and scientific innovation.

What are you looking for?

Most Recent

Policy Paper

Press

Blog

Report

Fact Sheet

Event

Resource

Pages

Leader

Author

Comment

Related Resources

Elise Shutzer

Elise Shutzer currently serves as Vice President of Public Affairs at PhRMA, leading issue communications for key topics including cost and access, hospitals, as well as strategic insights which oversees polling and message research activities. Shutzer is a seasoned leader with extensive experience in public policy advocacy, grassroots and public affairs. She most recently served as the Global Corporate Issue Head for Sustainability and Circularity at ExxonMobil leading advocacy campaigns on plastic waste, the circular economy and other environmental issues. Previously, Shutzer ran the energy and environmental grassroots and coalition development program at The Pew Charitable Trusts, and she spent over a decade at the Dewey Square Group, a prominent public affairs and communications firm.

It's time to modernize 340B: The case for a rebate model

August 19, 2026

Private equity's new play? Become a nonprofit to profit off 340B.

June 5, 2026

New "Goldmine” ad reveals hospitals hide how they profit from 340B markups

May 6, 2026

Survey confirms too many insured Americans face barriers to reliable health care

April 22, 2026

Modernizing 340B using rapid verification: The case for a rebate model 

April 20, 2026

70% DENIED: How insurance denials are delaying and preventing care for millions of Americans

April 14, 2026

No hassle, hidden markups or fees: AmericasMedicines.com

February 19, 2026

Three things you should know from the insurer CEO congressional hearings

January 26, 2026

New analysis finds 340B hospitals push patients toward costly care to boost profits

January 21, 2026

Can’t get your medicine? Don’t count on your insurer.

January 15, 2026

Middlemen mark up drug prices and keep discounts meant for you

November 10, 2025

PBMs say they want lower priced medicines, so why don’t they cover them?

October 7, 2025

PhRMA stresses importance of 340B Rebate Model Pilot

September 9, 2025

Elise Shutzer

Stay current on policy making

Sign up for email updates and follow us on social. 

About

Our Agenda

Policy Issues

Resources

Blog

Contact Us

Privacy Policy

Terms of Service

Facebook

Facebook

X

Twitter X

LinkedIn

LinkedIn

Instagram

instagram logo

America's Medicines

PhRMA Foundation

Voters for Cures

Working for Cures

Innovation.org

Please type your email

Success!

You've been added to the list